Nomura Asset Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-31,877
| Closed | -$268K | – | 1731 |
|
2023
Q3 | $268K | Hold |
31,877
| – | – | ﹤0.01% | 888 |
|
2023
Q2 | $400K | Buy |
31,877
+9,262
| +41% | +$116K | ﹤0.01% | 876 |
|
2023
Q1 | $372K | Hold |
22,615
| – | – | ﹤0.01% | 882 |
|
2022
Q4 | $338K | Buy |
+22,615
| New | +$338K | ﹤0.01% | 887 |
|
2022
Q2 | – | Sell |
-14,000
| Closed | -$419K | – | 1727 |
|
2022
Q1 | $419K | Hold |
14,000
| – | – | ﹤0.01% | 902 |
|
2021
Q4 | $430K | Buy |
+14,000
| New | +$430K | ﹤0.01% | 915 |
|
2021
Q3 | – | Sell |
-14,000
| Closed | -$512K | – | 1210 |
|
2021
Q2 | $512K | Hold |
14,000
| – | – | ﹤0.01% | 907 |
|
2021
Q1 | $484K | Hold |
14,000
| – | – | ﹤0.01% | 890 |
|
2020
Q4 | $582K | Hold |
14,000
| – | – | ﹤0.01% | 865 |
|
2020
Q3 | $596K | Buy |
+14,000
| New | +$596K | ﹤0.01% | 841 |
|